Role of Fluorophore Charge on the In Vivo Optical Imaging Properties of Near-Infrared Cyanine Dye/Monoclonal Antibody Conjugates
Overview
Authors
Affiliations
Near-infrared (NIR) fluorophores have several advantages over visible-light fluorophores, including superior light penetration in tissue and lower autofluorescence. We recently demonstrated that a new class of NIR cyanine dyes containing a novel C4'-O-alkyl linker exhibit greater chemical stability and excellent optical properties relative to existing C4'-O-aryl variants. We synthesized two NIR cyanine dyes with the same core structure but different indolenine substituents: FNIR-774 bearing four sulfonate groups and FNIR-Z-759 bearing a combination of two sulfonates and two quaternary ammonium cations, resulting in an anionic (-3) or monocationic (+1) charge, respectively. In this study, we compare the in vitro and in vivo optical imaging properties of monoclonal antibody (mAb) conjugates of FNIR-774 and FNIR-Z-759 with panitumumab (pan) at antibody-to-dye ratios of 1:2 or 1:5. Conjugates of both dyes demonstrated similar quenching capacity, stability, and brightness in target cells in vitro. However, FNIR-Z-759 conjugates showed significantly lower background in mice, resulting in higher tumor-to-background ratio. Thus, FNIR-Z-759 conjugates appear to have superior in vivo imaging characteristics compared with FNIR-774 conjugates, especially in the abdominal region, regardless of the dye-mAb ratio. These results suggest that zwitterionic cyanine dyes are a promising class of fluorophores for improving in vivo optical imaging with antibody-NIR dye conjugates.
Sato K, Okada T, Okada R, Yasui H, Yamada M, Isobe Y ACS Nano. 2025; 19(8):8338-8356.
PMID: 39964399 PMC: 11887486. DOI: 10.1021/acsnano.5c00104.
Shapiro M Front Oncol. 2024; 14:1379738.
PMID: 38746685 PMC: 11091260. DOI: 10.3389/fonc.2024.1379738.
Houvast R, Badr N, March T, de Muynck L, Sier V, Schomann T Eur J Nucl Med Mol Imaging. 2023; 51(8):2179-2192.
PMID: 37642704 PMC: 11178671. DOI: 10.1007/s00259-023-06407-w.
Matsuoka K, Yamada M, Fukatsu N, Goto K, Shimizu M, Kato A EBioMedicine. 2023; 95:104737.
PMID: 37558554 PMC: 10505829. DOI: 10.1016/j.ebiom.2023.104737.
Takahashi K, Yasui H, Taki S, Shimizu M, Koike C, Taki K Bioeng Transl Med. 2022; 7(3):e10388.
PMID: 36176626 PMC: 9471993. DOI: 10.1002/btm2.10388.